DNTH NASDAQ
Dianthus Therapeutics, Inc.
1W: +5.0%
1M: -1.8%
3M: +80.8%
YTD: +125.9%
1Y: +369.0%
3Y: +724.6%
5Y: -49.4%
$86.48
-3.15 (-3.51%)
Weekly Expected Move ±5.1%
$77
$82
$86
$91
$95
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$1M
Revenue
-79.5% YoY
$-11M
Net Income
+88.8% YoY
$-130M
Free Cash Flow
-43.4% YoY
83.6%
Gross Margin
-10050.3%
Op. Margin
-8819.4%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-2.7%
ROA-2.5%
ROIC-167.0%
Valuation
P/E-366.9
P/B3.5
EV/EBITDA-19.4
Leverage
Debt/Equity0.00
Current Ratio13.32
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z63.26
Beneish M-2.99